RE: Goodbye Good Buy?11 Aug 2024 16:15
Much appreciated , Max, opinions aid debate and thinking, Thanks. I’ve followed a largely similar path and agree with pretty much all your points, although I’m not convinced senior management has done a great job overall - I don’t rate TS as highly as others apparently do.
Having sold out when it last went over 800 (crazily IMO) I reentered at a much more sensible level, intending to hold a core amount and trade the highs. OCDO hasn’t been a great winner for me since then as it needs constant attention to make the most of it . I saw last year’s Exane target and the gap at 380 (around today’s price) as useful markers but traded at various levels in the meantime. However, recent events have caused me to see the fundamentals as less promising than a year ago and positive arguments here haven’t been overly convincing of late - too much ‘hope’ and personality bashing, which is always a sign of weakness in substance. I consequently consider it overpriced currently, suspecting that it may not break the three year trend as I’d been genuinely expecting until I saw market reaction to the Sobeys news and Bernstein downgrade. There’s a trading statement later in September which may determine how the clash with that significant three year trend ultimately turns out. In the meantime, the charts haven’t indicated a tempting buy point for me since mid July but I'll keep an eye on them for a bit longer. ATB.